Pharmacoeconomics: Open Access

Department of Pharmaceutical and Health Economics, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, Los Angeles, CA, USA

Publications

• Mini Review   
  Pharmacoeconomic Analysis of Drug-drug Interactions: Implications for Clinical Practice and Healthcare Costs
  Author(s): Rowan Ashwood*
  
  Pharmacoeconomic analysis serves as a valuable tool in assessing the economic impact of Drug-Drug Interactions (DDIs) within healthcare systems. DDIs occur when two or more drugs interact with each other, potentially altering their efficacy, safety, or pharmacokinetic properties. These interactions can lead to adverse drug reactions, treatment failure, and increased healthcare costs. Pharmacoeconomic analysis provides a systematic framework for evaluating the costs and outcomes associated with managing DDIs, helping policymakers and healthcare providers make informed decisions about resource allocation, intervention strategies, and patient care. One approach to pharmacoeconomic analysis of DDIs is Cost-Effectiveness Analysis (CEA), which compares the costs and health outcomes of different intervention strategies for preventing or managing drug interactions. Thi.. Read More»
  DOI: 10.37421/2472-1042.2024.9.223

  Abstract HTML PDF